Benefits of early diagnosis of coronary artery diseases and demand for effective treatment is expected to drive the United States interventional cardiology devices market for the forecast period.
According to TechSci Research report, “United States Interventional Cardiology Devices Market By Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others) By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By Company, By Region, Forecast & Opportunities, 2026”, The United States interventional cardiology devices market is expected to witness significant growth for the next five years. Heart related disease are considered the most serious health condition and is responsible for leading to death of patients. Therefore, the patients suffering from cardiovascular disease or those at high cardiovascular risk require early detection and treatment of diseases. Use of high-resolution technologies for example magnetic imaging resonance and computer tomography, optical coherence tomography is effective in identifying the cardiovascular disease during the first medical treatment procedure. Launch of novel products ensuring high accuracy and efficiency resulting in fewer traumas to patient and ensure quick recovery is expected to influence the market growth.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Number of patients visiting the hospital facilities for ailment other than coronavirus has significantly reduced even though emergency and OPD services are available in cardiology department. This has reduced the sales of interventional cardiology devices market and thereby affected the market adversely.
However, availability of alternate products may create hindrance in the growth of the interventional cardiology devices market.
Browse XX Figures spread through XX Pages and an in-depth TOC on “United States Interventional Cardiology Devices Market”.
United States interventional cardiology devices market is segmented into type, end user, regional distribution, and company. Based on product type, market can be further divided into angioplasty balloons, angioplasty stents, structural heart devices, catheters, plaque modification devices, hemodynamic flow alteration devices, and others. The hemodynamic flow alteration device is fragmented into embolic protection devices and chronic total occlusion devices. The embolic protection devices are in high demand due to advantages of these devices over chronic total occlusion devices for example the ability to capture the embryo debris without disturbing the continuous blood flow. The catheters segment is expected to register fastest incremental growth during the forecast period. The benefits offered by catheters such as occurrence of minimal complications, lower contrast agent usage and reduced haemostasis which are the significant factors contributing to high demand for catheters segment. Catheters in interventional cardiology are also cost-effective in nature over its other counterparts and ensure the patient safety along with the facility for faster patient mobilization.
Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc., are the leading players operating in United States interventional cardiology devices market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several interventional cardiology devices manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7516
Customers can also request for 10% free customization on this report.
“Growing adoption of advanced cardiovascular treatments and introduction of technologically advanced treatment is boosting the demand for interventional cardiology devices market. Rise in preference for minimally invasive surgeries due to faster recovery, minimal hospital stay and cost-effective nature over the traditional methods which require more invasive procedures such as coronary artery bypass surgery. Drug eluting stents are in high demand which are minimally invasive treatment procedure are coated with medication and released into the body without affecting the flow of the blood. These also reduces the need for repetitive angioplasty procedures to prevent the risk of heart pain and stroke. Favorable government intitaives for product development in addition with high patient awareness is expected to propel the growth of the interventional cardiology devices market until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Interventional Cardiology Devices Market By Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others) By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States interventional cardiology devices market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States interventional cardiology devices market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017